Project Grant K08AI181642

Award Date 7/19/24
Completion Date 6/30/29
Dollars Obligated $193K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
This $582,959 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to integrate universal HIV testing and treatment services into emergency department (ED) settings in South Africa. The grant funding will support a pilot study to assess the prevalence and characteristics of ED patients eligible for HIV prevention and treatment services, evaluate the uptake and continuation of...
This $825,988 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to leverage extensive social determinants and spatial data to reduce HIV incidence in Ending the HIV Epidemic (EHE) counties across the United States. The key products and services being delivered under this 4-year grant include: Creating transportation-based measures of pre-exposure prophylaxis (PrEP) accessibility at the county...
This $911,400 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to establish a comprehensive PREP (Pre-Exposure Prophylaxis) epidemiology, modeling, and surveillance system. The key objectives are to utilize national PREP prescription data, along with legal and policy analysis, to inform the U.S. HIV epidemic response and identify effective programs and policies for facilitating...
This $815,573 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Leland Stanford Junior University (Stanford University). The project aims to map the cell-intrinsic inflammatory networks induced during chronic, treated HIV infection in perinatally-infected adolescents, and define the viral factors driving this HIV-induced inflammation. The research will leverage a unique...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $820,845 to New York University (NYU) School of Medicine to conduct research on improving HIV outcomes for different population groups and settings. The research will use mathematical modeling to simulate how to optimize the distribution of resources across interventions, locations, and target populations to reduce HIV...
This $215,860 federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a mid-career investigator's research portfolio to improve the diagnosis, treatment, and prevention of HIV-related central nervous system (CNS) infections. The key products and services delivered include: Enrolling a prospective cohort of HIV-positive individuals with meningitis to enable...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $793,247 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to conduct research aimed at improving the health of people living with HIV. The key products and services to be delivered through this 5-year grant include: Developing and implementing a data-driven algorithm to assign validated...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to advance understanding of host-viral dynamics and potential therapeutic strategies for HIV eradication. The $794,045 award supports research at the University of California, San Francisco (UCSF) to investigate the role of class II cytokines, such as IL-10 and interferons, in controlling HIV across...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,361,442 to Emory University to develop an economical, rapid molecular test for detecting Hepatitis C Virus (HCV) and HIV from whole blood. The key objectives are: Adapting and automating RNA sample extraction and stabilization (RNAES) technology to extract and stabilize HCV/HIV RNA from capillary whole blood,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $148,824 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Foundation of the City University of New York (RFCUNY) - Graduate School of Public Health and Health Policy. The grant, awarded on August 2, 2024, funds a study to examine the interplay between COVID-19 and HIV, with a focus on understanding the impacts on HIV care, disparities, and long-term outcomes. The...

This $192,672 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports Dr. Christopher Bennett, an Assistant Professor of Emergency Medicine at Stanford University, in achieving two key objectives: (1) helping emergency departments (EDs) lead efforts to end the HIV epidemic in the U.S., and (2) transitioning from a junior investigator to an independent physician-scientist with expertise in economic analyses, implementation science, and qualitative methods.

Specifically, the grant funding will enable Dr. Bennett to: (1) investigate the cost-effectiveness of ED-based HIV screening in geographic areas targeted by the Ending the HIV Epidemic (EHE) initiative, and determine the incremental cost-effectiveness of HIV screening in all U.S. EDs; (2) create a typology of the HIV screening strategies used by 28 California EDs that recently received funding to implement or expand routine, opt-out HIV screening; and (3) employ qualitative interviews with frontline ED providers and individuals tested for HIV to illuminate barriers and facilitators encountered during the real-world implementation of these ED-based HIV screening programs. This work aims to identify effective strategies for making HIV screening routine in settings that serve high-risk populations, advancing the EHE initiative's goals.

Generated 5/13/25, 3:50 AM